НовостиBenzingaEvercore ISI Group Maintains Outperform on Medline, Raises Price Target to $44 Evercore ISI Group Maintains Outperform on Medline, Raises Price Target to $44 Benzinga 2026.11.05 14:23 (GMT+0) Открыть на Benzinga Другие новости